Trial Search Results

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Aminophylline
  • Other: Theophylline drug levels
  • Drug: Placebo

Phase:

N/A

Eligibility


Inclusion Criteria:

   1. Pediatric kidney transplant recipients less than 21 years of age

   2. Patients undergoing deceased donor (DD) kidney transplants

Exclusion Criteria:

   1. Known history of non-sinus tachycardia

   2. Multiple organ transplants recipients

   3. Severe liver dysfunction

Ages Eligible for Study

1 Year - 21 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Vivian Shih, MD
650-723-7903
Recruiting